Existing reports indicate that COL10A1 is highly expressed in the tumor stroma of breast, pancreatic, and gastrointestinal cancers, where its upregulation is typically associated with increased tumor invasiveness and poorer patient survival [29]. The gene discussed is COL10A1; the disease is neoplasm.